Long term stock investment...make $$$

[Doughboy]

Cranman,

That is pretty strange that he refused your order, but that is his perogative. Unfortunately, with the caps that are being placed on malpractice and medical lawsuit claims, many lawyers are now aiming their sites on brokers and wirehouses. Maybe that is what he is afraid of. He could mark the order unsolicited, and he would be fine...that is what I would do, and if he charges 2% on an unsolicited trade, you should fire him. If you bring the idea/order to him, then he should charge you a minimum commission, but if the idea is his, then 1-2% would be fair. Also, if you wanted to be safe, you could buy a put on the stock to protect yourself. As I said, I don't think the stock is goping to soar like rightside does, but at these levels, it is getting very attractive, and the newsletter I subscribe to also is still buying. If you have any questions anytime, get my e-mail from Jack.

 

[CranMan]

Dr.RIGHT SIDE & Dr.Doughboy -

I wanted to say thank you to the MadJack professors of Stock Market 101!

I appreciate the education regarding the MICU "play" and as of yet am still tracking the price.

Upon deciding to make a purchase I am going to have to seek out a broker in this area of Iowa that will handle the transaction.

Good luck to the both of you in your investing & sports wagering!

CranMan The CrazyMan

 

[wareagle]

 

[selkirk]

the stock has some legal issues, (lawsuits) not sure how strong the cases are...

some directors have left the company recently, and they issued a press release about how they were planning to reduce expenses ?

as for the product it seems interesting however this is a higher risk stock.

own a stock trades on Toronto Conju chem bought in Feb for $6.10 went on a run $15, sold $12.80, anyways held 25% of the orginal postion. came out with news went down $4.80 that day, closed at $5.45

the diabetes drug (conju chem )they are working on may not make it to market based on poor results. sold the remainder of the stock, and will track it.


if you invest in this sector best to invest in a basket of stocks.

thanks
selkirk

 

[Doughboy]

Selkirk,

My newsletter also owns and tracks Conjuchem. Do you want me to post his thoughts on the recent news?

 

[selkirk]

sounds good doughboy, if you want to start a seperate thread or just continue with this one.

the more information the better. in these jr. drug companies either pick one that does well or one that loses me 30%. I thought jr. gold/oil stocks were hard to figure out. LOL

thanks
selkirk

 

[freelancc]

:lol: :lol:

 

[DOGS THAT BARK]

I'd say the savvy investor on this one was the director Milligan who dumped large amount of shares share 2 months prior to to bout 50% drop on stock. Wasn't a planned sale so would assume he was very lucky orknew something.



30-Mar-04 MILLIGAN, DAVID V.
Director 124,375 Sale at $22 - $22.23 per share. $2,751,0002

 

[Doughboy]

New alerts below.

 

[Doughboy]

7/5/04


Vicuron (MICU) at $12.35/share and a market cap of $674 million seems like a solid buy. The recent sell-off reflects a delay in FDA approval for their antifungal antibiotic (anidulafungin). I believe this is a temporary setback and we will get more clarity in how MICU intends to get FDA approval shortly. Their other main program (dalbavancin) will have trial data later this year.

 

[Doughboy]

7/20/04



As for other stocks in the Model?Vicuron (MICU) keeps making new lows?but the likelihood of anidulafungin getting approved by the FDA is very high. The question is whether this will be a ?05 or?06 event. I think the market has factored in the worst case scenario. Also we will be seeing data on dalbavancin later this year. I think this will be a more important drug than the market appreciates. It will allow us to treat a variety of patients with resistant Staphylococcus aureus infections (MRSA) on an out patient schedule. Currently patients with hospital acquired MRSA infections need to be on IV Vancomycin twice daily, which means they have to stay in the hospital (community acquired MRSA can usually be treated with a variety of simple oral antibiotics). If approved the MICU drug will allow many of those patient to go home with weekly or twice-weekly visits to the outpatient infusion center. The biggest problem would come from allergic reactions since the drug stays around for such a long time?so far this is not a significant problem. The hospital Vancomycin market is huge?most hospitals use this antibiotic like water.

 

[RIGHT SIDE]

Doughboy...thanks for the info!! Keep it up! MICU is a strong company and they'll get through this low point...Great time to buy!!


RS

 

[Woodson]

9.69 -0.16 / -1.62% on 08/04/04

So... is it still a good buy?

 

[Doughboy]

Woodson,

I would say that you might be able to piece into a good position starting here. Maybe 25% of your total expected holding would be a good start. I am not sure that there is too much downside left in the price, but be ready to hop on the roller coaster for a bumpy ride.

 

[yyz]

Sounds like a movie!

Remember when Seth had his fish on the line, and the stock dropped like a stone after he bought it? He kept telling the guy, "We loved it then, we love it even more now!"

I hear Seth REALLY loves this shit at 9.39!!!!!



A broker using boiler room tactics gives customers only promising information about the stock and discourages them from doing any outside research. Boiler room salesmen typically use catchphrases like "it's a sure thing" or "opportunities like this happen once in a lifetime."

The North American Securities Administrators Association estimates that investors lose an estimated $10 billion a year--roughly $1 million an hour--to investment fraud promoted over the telephone.

 

[Doughboy]

That's funny YYZ. Remember that this stock is in the biotech sector, and needless to say it can be a very bumpy ride. Especially in smaller cap sized companies like MICU.

As a broker, that movie has been mentioned somewhere to me on a weekly basis since it came out.

I don't necessarily like how Right Side is pumping the stock either, and that is why I have tried to bring some logic into the conversations.

 

[Woodson]

FWIW

FWIW

I'm not that naive and have not acted on the mere suggestion of the stock. I do however hold an open mind and have looked at it.

Think I'll continue to watch it from the sidelines.

I would however like someone with more knowledgable experience to tell me why CNDD Coincorde America is not a good buy. Or if its just being purchased because of hype... It' s gone from 109 ?split? to 3 and now climbing up to 4.55 as we speaking... . Wouldn't mind putting in a couple hundred to see where it goes...

 

[Doughboy]

Looks like good news today on Phase III data for Dalbavancin. Stock is trading up $2 pre-market. Indicating $12.35.

 

[Woodson]

Nice... I had forgotten about this one...

 

[RIGHT SIDE]

MICU hopefully on the rise....jumped up like Doughboy said....it's around $12.55 right now on 8/12. I read that they had a great success with an antifungal medicine and will approach the board with it soon...it that gets approved WATCH OUT!! I got in when the stock was around where it's at now, so those of you who got in at around $9 a share...you are going to profit HUGE when this sucker goes up to expectations...patience is the key with this one guys. Doughboy keep plugging away with the info...VERY MUCH appreciated.....